Shared and Distinct Gut Microbiota in Spondyloarthritis, Acute Anterior Uveitis, and Crohn's Disease
Arthritis & Rheumatology · 2024-01 · 76 (1) · 48-58
DOI: 10.1002/art.42658 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 19.10.2023. Verfasst von Morgan Essex und 12 weiteren Autor:innen. Beteiligte Einrichtung: Experimental and Clinical Research Center (ECRC; a cooperation of the Max Delbrück Center and Charité-Universitätsmedizin), Max Delbrück Center for M…. Hauptthemen laut MEDLINE: Crohn Disease, Gastrointestinal Microbiome, Spondylarthritis, Uveitis, Anterior. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, German Research Foundation, German Federal Ministry for Health and Research (BMBF).
Abstract (Originalsprache)
Objective
Spondyloarthritis (SpA) is a group of immune‐mediated diseases highly concomitant with nonmusculoskeletal inflammatory disorders, such as acute anterior uveitis (AAU) and Crohn's disease (CD). The gut microbiome represents a promising avenue to elucidate shared and distinct underlying pathophysiology.
Methods
We performed 16S ribosomal RNA sequencing on stool samples of 277 patients (72 CD, 103 AAU, and 102 SpA) included in the German Spondyloarthritis Inception Cohort and 62 back pain controls without any inflammatory disorder. Discriminatory statistical methods were used to disentangle microbial disease signals from one another and a wide range of potential confounders. Patients were naive to or had not received treatment with biological disease‐modifying antirheumatic drugs (DMARDs) for >3 months before enrollment, providing a better approximation of a true baseline disease signal.
Results
We identified a shared, immune‐mediated disease signal represented by low abundances of Lachnospiraceae taxa relative to controls, most notably Fusicatenibacter , which was most abundant in controls receiving nonsteroidal antiinflammatory drug monotherapy and implied to partially mediate higher serum C‐reactive protein . Patients with SpA showed an enrichment of Collinsella , whereas human leukocyte antigen (HLA)‐B27+ individuals displayed enriched Faecalibacterium . CD patients had higher abundances of a Ruminococcus taxon, and previous conventional/synthetic DMARD therapy was associated with increased Akkermansia .
Conclusion
Our work supports the existence of a common gut dysbiosis in SpA and related inflammatory pathologies. We reveal shared and disease‐specific microbial associations and suggest potential mediators of disease activity. Validation studies are needed to clarify the role of Fusicatenibacter in gut‐joint inflammation, and metagenomic resolution is needed to understand the relationship between Faecalibacterium commensals and HLA‐B27. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Experimental and Clinical Research Center (ECRC; a cooperation of the Max Delbrück Center and Charité-Universitätsmedizin), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), and Charité-Univ…
- Medical Department of Gastroenterology, Infectiology and Rheumatology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
- Medical Department of Gastroenterology, Infectiology and Rheumatology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, and Berlin Institute of Health (BIH) at Charité-Universitätsmedizin Berlin, Berlin, Ge…
- ECRC, MDC, Charité-Universitätsmedizin Berlin and German Center for Cardiovascular Research (DZHK), Berlin, Germany.
- Department of Ophthalmology, Campus Virchow, Charité-Universitätsmedizin Berlin, Berlin, Germany.
- Helmholtz Center for Infection Research, Braunschweig, Germany, and Cluster of Excellence RESIST (EXC 2155), Hannover Medical School and Center for Individualized Infection Medicine (CiiM; a joint venture between the He…
ORCID-Profile: Morgan Essex, Valeria Rios Rodriguez, Judith Rademacher, Fabian Proft, Denis Poddubnyy
Förderung
- Deutsche Forschungsgemeinschaft
- German Research Foundation
- German Federal Ministry for Health and Research (BMBF)
- Novartis
- BIH-Charité Clinician Scientist Program
- Charité-Universitätsmedizin Berlin
- DFG
Zitieren
APA
Essex, M., Rios Rodriguez, V., Rademacher, J., Proft, F., Löber, U., Markó, L., Pleyer, U., Strowig, T., Marchand, J., Kirwan, J. A., Siegmund, B., Forslund, S. K., & Poddubnyy, D. (2024). Shared and Distinct Gut Microbiota in Spondyloarthritis, Acute Anterior Uveitis, and Crohn's Disease. Arthritis & Rheumatology, 76(1), 48-58. https://doi.org/10.1002/art.42658
Vancouver
Essex M, Rios Rodriguez V, Rademacher J, Proft F, Löber U, Markó L, et al. Shared and Distinct Gut Microbiota in Spondyloarthritis, Acute Anterior Uveitis, and Crohn's Disease. Arthritis & Rheumatology. 2024;76(1):48-58. doi:10.1002/art.42658
BibTeX
@article{Essex2024,
author = {Essex, Morgan and Rios Rodriguez, Valeria and Rademacher, Judith and Proft, Fabian and Löber, Ulrike and Markó, Lajos and Pleyer, Uwe and Strowig, Till and Marchand, Jérémy and Kirwan, Jennifer A and Siegmund, Britta and Forslund, Sofia K and Poddubnyy, Denis},
title = {Shared and Distinct Gut Microbiota in Spondyloarthritis, Acute Anterior Uveitis, and Crohn's Disease},
journal = {Arthritis & Rheumatology},
year = {2024},
volume = {76},
number = {1},
pages = {48--58},
doi = {10.1002/art.42658}
}
EUVIMED